SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Kirk's Market Thoughts
COHR 191.85+0.5%3:09 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kirk © who wrote (11775)8/23/2021 4:24:10 PM
From: Logain Ablar3 Recommendations

Recommended By
Kirk ©
Thomas M.
Winfastorlose

  Read Replies (1) of 26824
 
Hi Kirk,

Its not the MD's its the FDA. They haven't approved it for off label use.

The MD's have to worry about the insurers who pay them if it's contrary to the FDA.

My opinion of the conflict and one reason why I don't trust the FDA.
  • If there is a viable treatment - the FDA would not be able to issue Emergency Use Authorization.
  • If a vaccine is under EUA then the schools and employers would have difficulty banning / firing students / employees as it would conflict with a federal statute.
  • The FDA now gives full approval based on interim phase III trial results versus waiting for the end of the trial. This gives cover to the employers and schools on their vaccine requirements (at least for the Pfizer shot).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News